MRX Financial Facts
Income tax expense: 13.09MCost of product revenues (1): 17.17M
See Full Income Statement
Less: Treasury stock: 363.94M
Managed Care And Medicaid Reserves: 59.42M
See Full Balance Sheet
Medicis Pharmaceutical Corp. (MRX) Earnings
|
Expand Research on MRX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +26.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -3.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/8/12  |
Q212 | $0.52 | $0.46 | +$0.06 | $197M | $191.51M | N/A |  | | Details | |
| 5/8/12 |
Q112 | $0.60 | $0.42 | +$0.18 | $201.7M | $185.15M | N/A | | | Details | |
| 2/27/12 |
 |
Q411 | $0.87 | $0.55 | +$0.32 | $180.7M | $179.2M | N/A | | | Details |
| 11/8/11 |
|
Q311 | $0.56 | $0.61 | -$0.05 | $184.7M | $187.06M | = | | | Details |
| 8/8/11 |
|
Q211 | $0.64 | $0.64 | $0.00 | $190.8M | $188.79M | = | | | Details |
| 5/5/11 |
|
Q111 | $0.50 | $0.49 | +$0.01 | $164.9M | $168.98M | = | | | Details |
| 2/25/11 |
|
Q410 | $0.60 | $0.60 | $0.00 | $182.1M | $184.16M | = | | | Details |
